Blood test for dementia-linked Alzheimer’s changes matched spinal fluid tests
☕ Includes a question for the family ↓
Alzheimer's and dementiaPart of a story we are following · 14 articles · See every update
If you or someone you love has noticed memory problems, a new study looked at a blood test for the brain changes behind Alzheimer’s disease, the most common cause of dementia. Until now, the standard lab check has often meant a spinal tap.
In a study of three groups of people (129 at a memory clinic, 220 in primary care and 165 in a research group), blood tests for Alzheimer’s changes were about as accurate as spinal fluid tests at spotting amyloid, a protein buildup in the brain. All of the people studied had symptoms.
How the study worked
Researchers compared two blood measures, called plasma p-tau217 and the p-tau217/Aβ42 ratio, with two spinal fluid tests. All of the tests used cutoffs cleared by regulators. Each result was checked against a brain scan that shows amyloid. This was an observational study published in Nature Aging on November 18, 2026, and it included only people who already had symptoms, so it does not tell us how these tests would work in people with no symptoms.
What they found
The blood tests picked out amyloid in the brain well. Measured as area under the curve, their scores ranged from 0.90 to 0.96.
The researchers then asked how often each test got the answer right. With a single cutoff, the blood measure p-tau217 was right 83% to 91% of the time. The ratio version was right 83% to 92% of the time. The spinal fluid tests were right 88% to 90% of the time. Across all three groups, the differences between blood and spinal fluid were small enough that the researchers called them comparable.
The team also tried a two-cutoff approach for p-tau217. In the two clinical groups, the memory clinic and primary care, it was right 90% to 97% of the time. The spinal fluid test in those groups was right 91% of the time. Again, the results were comparable.
In plain terms: for people with symptoms, a blood draw told doctors about as much as a spinal tap did about whether amyloid was present.
What does amyloid have to do with dementia?
Alzheimer’s disease is the most common cause of dementia. Two signs in the brain are amyloid and a protein called tau. Doctors can see amyloid on a special brain scan, which is the yardstick this study used. The blood and spinal fluid tests are indirect ways to find the same thing.
A test that shows amyloid is present does not by itself tell you how a person’s memory will change or how fast. It is one piece of a larger picture that also includes symptoms, history and an exam.
Why a blood test matters
A blood draw is something almost everyone has had. It can be done in a regular clinic and does not need the more involved setup of a spinal tap. The tests in this study run on fully automated lab platforms, which the authors describe as accessible and cost-effective.
The study included a primary care group, and across all three groups the blood tests were comparable to the spinal fluid tests with a single cutoff.
What you can do today
If memory changes are on your mind, write down what you have noticed: what happened, when, and how often. At your next primary care visit, bring the list and ask what testing options are available. Blood tests like these are new, so it is fair to ask whether they are offered where you live.
For clinicians and researchers
Design: Cohort comparison of Lumipulse plasma p-tau217 and p-tau217/Aβ42 against regulatory-authorized CSF biomarkers (Aβ42/Aβ40, p-tau181/Aβ42), with Aβ-PET visual read as reference, in a memory clinic (n = 129), a primary care (n = 220) and a research cohort (n = 165).
Main result: Plasma biomarkers identified Aβ pathology with areas under the curve between 0.90 and 0.96. With one cutoff, plasma p-tau217 (83-91%) and p-tau217/Aβ42 (83-92%) had accuracies comparable to CSF (88-90%) across cohorts (all P ≥ 0.05).
Main limitation: Reference standard was Aβ-PET visual read, a surrogate of AD pathology, and the conclusion applies to symptomatic individuals; the two-cutoff comparison was limited to the clinical cohorts.
Open question: Whether the comparable performance holds with cohort-derived cutoffs and in asymptomatic populations, and whether it translates into clinical outcomes, remains to be tested.
Talk about it at home
Your blood travels all through your body, and it carries tiny bits of news from the brain, a bit like a mail carrier picking up letters from every house on the street. Scientists wanted to know if reading those little notes in a small blood sample could work as well as other, harder methods. So they checked every blood result against a special picture of the brain, the way you check your answers against the answer key.
Try it at home
Look up together how doctors can see inside a living body without opening it, and each of you pick the picture you find most surprising to show the family at dinner.
Keep exploring
Copies this article and its questions so you can paste them into ChatGPT, Claude, Gemini or the AI you use, and keep the conversation going.
Cite this article
Mongevity Desk. Blood test for dementia-linked Alzheimer’s changes matched spinal fluid tests. Mongevity. Published November 19, 2026. Accessed November 22, 2026. https://mongevity.science/brain/2026/11/blood-test-alzheimers-matched-spinal-fluid-tests/Mongevity Desk. Blood test for dementia-linked Alzheimer’s changes matched spinal fluid tests [Internet]. Mongevity; 2026 Nov 19 cited 2026 Nov 22]. Available from: https://mongevity.science/brain/2026/11/blood-test-alzheimers-matched-spinal-fluid-tests/Mongevity Desk. (2026, November 19). Blood test for dementia-linked Alzheimer’s changes matched spinal fluid tests. Mongevity. https://mongevity.science/brain/2026/11/blood-test-alzheimers-matched-spinal-fluid-tests/
<a href="https://mongevity.science/brain/2026/11/blood-test-alzheimers-matched-spinal-fluid-tests/">Blood test for dementia-linked Alzheimer’s changes matched spinal fluid tests</a>
Free to share or quote with credit and a link.
Questions and answers
- Can a blood test diagnose Alzheimer's disease?
- In this study, blood tests found amyloid in the brain about as accurately as spinal fluid tests in people with symptoms. Doctors still weigh test results together with symptoms, history and an exam.
- How accurate were the blood tests?
- With one cutoff, plasma p-tau217 was right 83% to 91% of the time, compared with 88% to 90% for spinal fluid tests.
- Who was in the study?
- People with symptoms in three groups: 129 at a memory clinic, 220 in primary care and 165 in a research group.
- Does this mean healthy people should get tested?
- The study only looked at people who already had symptoms, so it does not answer that question.





